SSDataProtection object

Notification to DP Authority/ Ombudsmann is mandatory

No

Approval/ authorisation required

No

Additional Information

Confidentiality: Prevention of disclosure, to other than authorized individuals, of a sponsor's proprietary information or of a volunteer's identity.

The confidentiality of records that could identify volunteers should be protected, respecting the privacy and confidentiality rules in accordance with the applicable regulatory requirements.

The monitors, auditors, the Ethics committee, Turkey Pharmaceuticals and Medical Device Agency and the other relevant health authorities will have direct access to the original medical records of the volunteer, but such information will be kept confidential.

Pursuant to the applicable regulation requirements, the records directly identifying the volunteer will be kept confidential, they will not publicly disclosed and the identity of the volunteer will be still kept confidential even if results of the trial are published (Guideline for Good Clinical Practice 2014).

Clinical trials conducted in humans, including studies to investigate bioavailability and bioequivalence, with drugs, medicinal and biological products, or herbal medicinal products, whether authorized or licensed, and for observational drug studies will be entered in a public register, respecting the privacy of personal information (Regulation on Clinical Trials of Medicinal and Biological Products 2014).

Feedback